In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19
- PMID: 15483195
In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19
Abstract
The specific cytochrome P450 (P450) isoforms mediating the biotransformations of clobazam (CLB) and those of its major metabolites, N-desmethylclobazam (NCLB) and 4'-hydroxyclobazam were identified using cDNA-expressed P450 and P450-specific chemical inhibitors. Among the 13 cDNA-expressed P450 isoforms tested, CLB was mainly demethylated by CYP3A4, CYP2C19, and CYP2B6 and 4'-hydroxylated by CYP2C19 and CYP2C18. CYP2C19 and CYP2C18 catalyzed the 4'-hydroxylation of NCLB. The kinetics of the major biotransformations were studied: CYP3A4, CYP2C19, and CYP2B6 mediated the formation of NCLB with Km = 29.0, 31.9, and 289 microM, Vmax = 6.20, 1.15, and 5.70 nmol/min/nmol P450, and intrinsic clearance (CLint) = 214, 36.1, and 19.7 microl/min/nmol P450, respectively. NCLB was hydroxylated to 4'-hydroxydesmethylclobazam by CYP2C19 with Km = 5.74 microM, Vmax = 0.219 nmol/min/nmol P450, and CLint = 38.2 microl/min/nmol P450 (Hill coefficient = 1.54). These findings were supported by chemical inhibition studies in human liver microsomes. Indeed, ketoconazole (1 microM) inhibited the demethylation of CLB by 70% and omeprazole (10 microM) by 19%; omeprazole inhibited the hydroxylation of NCLB by 26%. Twenty-two epileptic patients treated with CLB were genotyped for CYP2C19. The NCLB/CLB plasma metabolic ratio was significantly higher in the subjects carrying one CYP2C19*2 mutated allele than in those carrying the wild-type genotype. CYP3A4 and CYP2C19 are the main P450s involved in clobazam metabolism. Interactions with other drugs metabolized by these P450s can occur; moreover, the CYP2C19 genetic polymorphism could be responsible for interindividual variations of plasma concentrations of N-desmethylclobazam and thus for occurrence of adverse events.
Copyright 2004 The American Society for Pharmacology and Experimental Therapeutics
Similar articles
-
In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.Drug Metab Dispos. 2006 Apr;34(4):608-11. doi: 10.1124/dmd.105.007237. Epub 2006 Jan 13. Drug Metab Dispos. 2006. PMID: 16415114
-
Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.Drug Metab Dispos. 1996 Oct;24(10):1081-7. Drug Metab Dispos. 1996. PMID: 8894508
-
Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.Biochem Pharmacol. 2007 Jun 15;73(12):2020-6. doi: 10.1016/j.bcp.2007.03.012. Epub 2007 Mar 19. Biochem Pharmacol. 2007. PMID: 17433262
-
Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.Ther Drug Monit. 2013 Feb;35(1):30-47. doi: 10.1097/FTD.0b013e31827ada88. Ther Drug Monit. 2013. PMID: 23318278 Free PMC article. Review.
-
Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines.J Clin Pharm Ther. 2007 Aug;32(4):333-41. doi: 10.1111/j.1365-2710.2007.00829.x. J Clin Pharm Ther. 2007. PMID: 17635335 Review.
Cited by
-
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
-
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.Epilepsia. 2020 Sep;61(9):1854-1868. doi: 10.1111/epi.16674. Epub 2020 Sep 12. Epilepsia. 2020. PMID: 32918835 Free PMC article. Review.
-
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.J Clin Pharmacol. 2020 Oct;60(10):1304-1313. doi: 10.1002/jcph.1634. Epub 2020 Jul 11. J Clin Pharmacol. 2020. PMID: 32652616 Free PMC article. Clinical Trial.
-
Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy.Eur J Clin Pharmacol. 2014 Oct;70(10):1203-10. doi: 10.1007/s00228-014-1719-5. Epub 2014 Jul 22. Eur J Clin Pharmacol. 2014. PMID: 25048408
-
Sucralose, a synthetic organochlorine sweetener: overview of biological issues.J Toxicol Environ Health B Crit Rev. 2013;16(7):399-451. doi: 10.1080/10937404.2013.842523. J Toxicol Environ Health B Crit Rev. 2013. PMID: 24219506 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases